Table 1.
Baseline and TAVR procedural characteristics categorized by sex.
| Total | Male | Female | P-Value | |
|---|---|---|---|---|
| Population, n (%) | ||||
| Unweighted | 30,153 | 16,108 (53.4) | 14,045 (46.6) | <0.001 |
| Weighted | 150,647 | 80,477 (53.4) | 70,170 (46.6) | |
| Age, years % | <0.001 | |||
| 18–49 | 0.4 | 0.5 | 0.3 | |
| 50–59 | 1.6 | 1.9 | 1.3 | |
| 60–69 | 8.3 | 8.7 | 7.7 | |
| 70–79 | 26.9 | 28.6 | 25.0 | |
| >80 | 62.8 | 60.3 | 67.7 | |
| Race, % | <0.001 | |||
| White | 82.7 | 83.8 | 81.6 | |
| Comorbidities, % | ||||
| Hypertension | 52.3 | 50.3 | 54.5 | <0.001 |
| Hyperlipidemia | 65.6 | 67.5 | 63.5 | <0.001 |
| Cerebrovascular disease | 5.1 | 5.0 | 5.2 | 0.44 |
| Congestive heart failure | 28.8 | 29.3 | 28.3 | 0.07 |
| Diabetes mellitus | 35.1 | 37.1 | 32.8 | <0.001 |
| Renal failure | 35.9 | 40.3 | 30.9 | <0.001 |
| Chronic pulmonary disease | 30.9 | 31.0 | 30.7 | 0.60 |
| Peripheral vascular disorders | 26.8 | 29.4 | 23.9 | <0.001 |
| Prior CAD/IHD | 27.6 | 30.4 | 24.3 | <0.001 |
| Prior PCI | 9.4 | 10.6 | 8.1 | <0.001 |
| Prior Pacemaker/ICD/CRTD | 13.0 | 15.2 | 10.5 | <0.001 |
| Prior sternotomy, % | 32.0 | 41.3 | 21.4 | <0.001 |
| Deyo-CCI, % | <0.001 | |||
| 0 | 6.3 | 5.5 | 7.2 | |
| 1 | 11.2 | 9.8 | 12.8 | |
| 2 or higher | 82.5 | 84.7 | 80.0 | |
| Length of stay (days) | 5.7 ± 0.1 | 5.5 ± 0.1 | 6.0 ± 0.1 | 0.001 |
| Mortality | 2.3 | 2.1 | 2.7 | 0.001 |
CAD, cardiovascular disease; CRTD, cardiac resynchronization therapy devices; Deyo-CCI, Deyo-Charlson Comorbidity Index; ICD, implantable cardioverter-defibrillator; IHD, ischemic heart disease; TAVR, transcatheter aortic valve replacement.